We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Graphene Composites (GC) is a nano-materials technology company engaged in creating strongest, lightest, and most resilient materials. Using graphene and aerogels, GC creates high-performance composite armours, aerospace and renewable energy products. GC Shield active shooter protection for schools has received strong support from politicians, police and school authorities in the US and signals noteworthy revenue and profit potential.
days to go: Expired investment: £497,020
Helping online retailers run profitable operations by managing their orders, stock levels and couriers. Veeqo's software has been implemented in more than 300 retailers' systems and processes transactions with an average value of £16m per month. Businesses can access their data from almost any smart device and Veeqo have also released Scanner for all retailers, a hardware device with functionalities similarly used by Amazon in their distribution warehouses. Revenue is generated via retailers paying a regular licensing fee to use the Veeqo platform. This can range from £4,000 to £20,000 per annum. In addition, retailers can also lease the Veeqo Scanner from the company. Funds will allow Veeqo to develop products that can be used in-store at POS systems, as well as strengthen the business further in the UK.
days to go: Expired investment: £126,550
Hill and friends is a luxury handbag retailer.  They design and supply high quality women’s bags. Emma and Georgia was the creative and brand directors that helped mulberry gain their success from increasing their revenues from £51m in 2008 to 169m in 2012.
days to go: Expired investment: £318,231
Postio is a secure, dynamic, community driven delivery system. Postio offer the option of same-day and within-the-hour delivery to all. Sending and receiving parties are able to track their driver and therefore their package in realtime.  
days to go: Expired investment: £35,220
Intelligent Health aim to get the whole community active by providing games and incentives such as ''beat the street''. By providing schools and communities with friendly competition to walk and cycle more by tapping their cards on ''beat boxes'', and with prizes and league tables on offer, Intelligent health are bringing communities together. 
days to go: Expired investment: £700,000
TOG designs handmade kitchen knives that are forged in the Samurai sword. By working with craftsmen in Seki, Japan, this company has produced knives and a brand that met its customers' needs. It has been endorsed by ten Michelin star chefs and appeared on cooking shows such as Masterchef. In 2017 and 2018, TOG Knives reached 18k profit (EBITDA £19.5k). Currently, it is aiming to be the UK's No.1 premium knife brand by helping people realise how enjoyable food preparation is, only if, one owns the right knife. With the fund raised, it will purchase stock, grow its team, shift its staff to full time and hiring new people.
days to go: Expired investment: £193,810
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph